van den Heuvel M G W, Bast A, Ambergen A W, van der Hulst R R W J
Department of Plastic, Reconstructive and Hand Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
J Transplant. 2012;2012:504081. doi: 10.1155/2012/504081. Epub 2012 May 9.
Background. Statins and other cardiovascular medication possess antioxidant capacity. It was examined whether chronic use of these medications protects from the development of ischemia-reperfusion (I/R) related complications after DIEP (Deep Inferior Epigastric Perforator Free Flap) surgery. This paper contains a literature study on the antioxidant working mechanisms of these drugs. Methods. Medical information of 134 DIEP patients (173 flaps) was studied from their medical files. Patient and operative characteristics were registered, as well as I/R related complications. Results. Of the group that didnot use statins, 16.3% developed complications versus 30.8% amongst patients that did use these drugs (P = 0.29). Amongst patients that chronically use other cardiovascular medication, 26.8% developed I/R related complications versus 14.4% of the patients without medication (P = 0.10). Conclusions. Chronic use of statins or other cardiovascular medication didnot decrease the occurrence of I/R related complications after DIEP surgery. Therefore, research should be aimed at evaluating short-term pre-treatment with statins.
背景。他汀类药物及其他心血管药物具有抗氧化能力。本研究旨在探讨长期使用这些药物是否能预防腹壁下动脉穿支游离皮瓣(DIEP)手术后缺血再灌注(I/R)相关并发症的发生。本文包含了关于这些药物抗氧化作用机制的文献研究。方法。从134例DIEP患者(173块皮瓣)的病历中研究其医疗信息。记录患者和手术特征以及I/R相关并发症。结果。未使用他汀类药物的患者中,16.3%出现并发症,而使用这些药物的患者中这一比例为30.8%(P = 0.29)。长期使用其他心血管药物的患者中,26.8%出现I/R相关并发症,而未使用药物的患者中这一比例为14.4%(P = 0.10)。结论。长期使用他汀类药物或其他心血管药物并不能降低DIEP手术后I/R相关并发症的发生率。因此,研究应致力于评估他汀类药物的短期预处理效果。